drugset / Trial / NCT02578602

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

NCT02578602

NaSingle-groupOpen-labelDiagnostic

Summary

This pilot clinical trial studies magnetic resonance imaging (MRI) with gadoxetate disodium in measuring tumors in patients with liver cancer. Diagnostic procedures, such as MRI with gadoxetate disodium, may help find and diagnose liver cancer and find out how far the disease has spread. It is not yet known whether MRI with gadoxetate disodium provides a more precise measurement of liver tumors than standard computed tomography (CT).

Timeline

Start
2010-10
Primary completion
2014-11
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoxetate Disodium Diagnostic / imaging agent Intravenous